miRNA Expression Analyses in Prostate Cancer Clinical Tissues.


A critical challenge in prostate cancer (PCa) clinical management is posed by the inadequacy of currently used biomarkers for disease screening, diagnosis, prognosis and treatment. In recent years, microRNAs (miRNAs) have emerged as promising alternate biomarkers for prostate cancer diagnosis and prognosis. However, the development of miRNAs as effective… (More)
DOI: 10.3791/53123


Cite this paper

@article{Bucay2015miRNAEA, title={miRNA Expression Analyses in Prostate Cancer Clinical Tissues.}, author={Nathan Bucay and Varahram Shahryari and Shahana Majid and Soichiro Yamamura and Yozo Mitsui and Z. Laura Tabatabai and Kirsten Lynn Greene and G. R. Deng and Rajvir Dahiya and Yuichiro Tanaka and Sharanjot Saini}, journal={Journal of visualized experiments : JoVE}, year={2015}, volume={103} }